Clinical Trial Update: Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HL-1186 for diabetic peripheral neuropathy-related pain is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• HL-1186

Snippet

Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: NOT_YET_RECRUITING